Lucid Diagnostics, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US54948X1090
USD
1.06
0.05 (4.95%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Beyond Air, Inc.
Prenetics Global Ltd.
Pro-Dex, Inc.
Wrap Technologies, Inc.
CollPlant Biotechnologies Ltd.
Milestone Scientific, Inc.
Lucid Diagnostics, Inc.
VolitionRX Ltd.
Rockwell Medical, Inc.
Cardiff Oncology, Inc.
Cue Health, Inc.
Why is Lucid Diagnostics, Inc. ?
1
With a Negative Book Value, the company has a Weak Long Term Fundamental Strength
  • Poor long term growth as Net Sales has grown by an annual rate of 39.90% and Operating profit at -245.14% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -49.47
2
Flat results in Jun 25
  • OPERATING CASH FLOW(Y) Lowest at USD -43.06 MM
  • DEBTORS TURNOVER RATIO(HY) Lowest at 16.36 times
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 11.18%, its profits have fallen by -5.6%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Lucid Diagnostics, Inc. for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Lucid Diagnostics, Inc.
10.22%
0.61
75.62%
S&P 500
13.22%
0.61
20.17%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
39.90%
EBIT Growth (5y)
-245.14%
EBIT to Interest (avg)
-49.47
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-1.57
Sales to Capital Employed (avg)
0.13
Tax Ratio
0
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
16.59%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
-25.96
EV to EBIT
-3.10
EV to EBITDA
-3.16
EV to Capital Employed
48.49
EV to Sales
35.47
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-1564.48%
ROE (Latest)
Negative BV
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
NET PROFIT(HY)

Higher at USD -23.71 MM

RAW MATERIAL COST(Y)

Fallen by -39.35% (YoY

EPS(Q)

Highest at USD -0.08

-4What is not working for the Company
OPERATING CASH FLOW(Y)

Lowest at USD -43.06 MM

DEBTORS TURNOVER RATIO(HY)

Lowest at 16.36 times

Here's what is working for Lucid Diagnostics, Inc.
Net Profit
Higher at USD -23.71 MM
than preceding 12 month period ended Jun 2025
MOJO Watch
In the half year the company has already crossed Net Profit of the previous twelve months

Net Profit (USD MM)

EPS
Highest at USD -0.08
in the last five periods
MOJO Watch
Increasing profitability; company has created higher earnings for shareholders

EPS (USD)

Raw Material Cost
Fallen by -39.35% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin

Raw Material Cost as a percentage of Sales

Here's what is not working for Lucid Diagnostics, Inc.
Operating Cash Flow
Lowest at USD -43.06 MM and Fallen
In each year in the last three years
MOJO Watch
The company's cash revenues from business operations are falling

Operating Cash Flows (USD MM)

Debtors Turnover Ratio
Lowest at 16.36 times
in the last five Semi-Annual periods
MOJO Watch
Company's pace of selling Debtors has slowed

Debtors Turnover Ratio